• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, July 14, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home

OA complaint dismissed: committee rules in favour of Insight

by Staff Writer
October 22, 2019
in News
Reading Time: 5 mins read
A A
Share on FacebookShare on Twitter

Following an investigation by Insight into OA’s corporate governance, OA president and chairman Mr Darrell Baker informed mbers the organisation had lodged a complaint with the Media, Entertainment and Arts Alliance (MEAA).OA’s accusations stmed from Insight’s report, titled Optometry Australia mbership ‘Confidential’, which detailed the organisation’s refusal to place its current mbership number on the public record. As previously reported, of the 15 health-related associations contacted by Insight, OA rains the only one not willing to transparently release its annual mbership number.Following numerous requests for information, Insight questioned Baker on 5 July about whether OA would keep this number a secret from its own mbers.He was asked: “If a current mber of Optometry Australia requests a precise mbership number (the October 2018 number, for example) do you, as Board Chairman, undertake to ensure the information will be provided to the mber, without question?”Rather than answer the question, Baker filed a complaint with the MEAA’s National Ethics Committee. The MEAA is the journalists’ union, and requires mbers to uphold a code of ethics.Underlying the code are the principles of honesty, fairness, independence and respect for the rights of others. The code states: “Journalists search, disclose, record, question, entertain, comment and rber. They inform citizens and animate docracy. They scrutinise power, but also exercise it, and should be responsible and accountable”.Baker’s complaint reads: “It is our strong view that Mr [Coleby] Nicholson and Mr [Callum] Glennen’s aggressive communications and intimidation in seeking information over and above what we have already provided is not in the public interest as the Federal Government, Department of Health, the Australian Health Practitioner Regulation Authority, the ACCC and our own mbers, do not dand this information.”Baker’s letter also confirmed to the MEAA that in answering the request for its actual mbership number, OA CEO Ms Lyn Brodie had previously provided Insight with a mbership estimate – derived from calculating a percentage of the Optometry Board of Australia’s total registrants – rather than its own internal mbership figure.{{quote-A:R-W:400-I:2-Q:“Whilst managing this issue, we have continued to respond professionally to questions on various subject matters. In fact, a reasonable percentage of Insight’s content contains references to Optometry Australia and our initiatives.”-WHO:Darrell Baker, president OA}}The complaint alleges a breach of MEAA Code of Ethics standards four, five and six, which relate to accuracy, fairness, independence, conflicts of interest and advertising.Baker’s correspondence recognised the many other articles published by Insight about OA’s activities: “Whilst managing this issue, we have continued to respond professionally to Gunnamatta Media questions on various subject matters. In fact, a reasonable percentage of Insight’s content contains references to Optometry Australia and our initiatives.”MEAA National Ethics Committee decisionIn its response, the MEAA panel outlined OA’s complaint and advised that Insight journalist Glennen – the article’s author – is a mber of the MEAA, while publisher Nicholson is not and could not be reviewed.It wrote: “The panel spent significant time reviewing and discussing the complaint, and after due consideration has reached unanimous findings.”It concluded Glennen had not acted inappropriately and his articles accurately reported that OA had not provided its mbership figure as other organisations had.“The panel is of the view that Mr Glennen’s correspondence with Optometry Australia officers is professional and not aggressive or intimidating. He clearly, and firmly but politely, made his points about the fact that OA had not provided its actual mbership numbers, which other like organisations have.“He asked quite reasonable questions. The story is accurate in saying that OA has not revealed its actual mbership numbers – only a percentage and a calculation based on that percentage which is not the actual mbership number.”The ruling went on to state: “The article written by Mr Glennen is professional and deals with an issue relevant to his trade readership: why is Optometry Australia the only one of 15 organisations in the health field to refuse to reveal actual mbership numbers?”The panel also believed that Insight’s articles had sufficiently presented OA’s views and answers.“Optometry Australia’s side of the story got a full and fair run. What Mr Glennen wrote in his lead paragraph of the May 31 story was true: ‘Optometry Australia’s (OA) mbership figure is shrouded in obscurity, with Insight unable to ascertain the organisation’s current tally after initially being told the information was “confidential”.’“Mr Glennen was indeed at first told the mbership numbers were confidential , and compared to the way the other organisations are transparent on their mbership, OA’s approach of listing a percentage of another organisation’s figures could reasonably be argued to be obscure.”Accordingly, on 19 August the MEAA National Ethics Committee dismissed OA’s complaint.Baker also complained to the Australian Press Council (APC) about Glennen’s article, Gunnamatta Media and Nicholson. The APC decided “not to proceed with [the complaint]”.While the APC can deal with complaints against publications, it does not deal with complaints about individual journalists or editors. The APC advised OA about the outcome and the complaint is now closed. More readingOptometry Australia mbership confidential Optometry Australia holds firm on confidential mbership number 

Related Posts

The capsule collection draws from Carrera’s historic colours – black, white and red. Image: Carrera.

Carrera celebrates milestone with limited-edition collection

by Rob Mitchell
July 14, 2026

To celebrate its 70th anniversary, Carrera has announced the introduction of an exclusive Made in Italy limited-edition capsule collection that...

The Light Adjustable Lens is now available in Australia and New Zealand. Image: RxSight.

Light Adjustable Lens to be unveiled at AUSCRS

by Rob Mitchell
July 13, 2026

Now available in Australia and New Zealand, the RxSight Light Adjustable Lens (LAL) is the first and only intraocular lens (IOL) that enables postoperative refractive customisation....

UNSW has achieved a top ranking. Image: UNSW.

UNSW named No. 1 in world for optometry research excellence

by Staff Writer
July 9, 2026

The UNSW School of Optometry & Vision Science has been recognised as the world's leading optometry school for research excellence,...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Products
    • Ophthalmic Treatments
      • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited